

Please try another search
Sarepta Therapeutics (NASDAQ:SRPT) shares fell as much as 14.8% in early Wednesday trading after the medical research company said the U.S. Food and Drug Administration (FDA) informed the company it...
Investing.com -- Stocks are falling on Wednesday as negotiations on the debt ceiling dragged on with the deadline swiftly approaching. Here are the market movers for May 24. Abercrombie & Fitch...
By Bhanvi Satija and Pratik Jain (Reuters) -Contract drug manufacturer Catalent (NYSE:CTLT) Inc on Friday slashed its full-year forecasts for profit and sales and delayed its quarterly results for...
By David Carnevali NEW YORK (Reuters) - Investors are scrambling to assess the fallout of a U.S. regulatory challenge against Amgen Inc (NASDAQ:AMGN)'s proposed $27.8 billion acquisition of Horizon...
By Diane Bartz and Leroy Leo WASHINGTON (Reuters) -The U.S. Federal Trade Commission said on Tuesday it has filed a lawsuit to stop Amgen Inc (NASDAQ:AMGN)'s $27.8 billion acquisition of Horizon...
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT), which are currently halted, are set to open higher Monday following a positive FDA Advisory Committee vote for Duchenne muscular dystrophy gene...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review